Syneos Health, Inc. (SYNH)
- GlobeNewswire
Syneos Health Leaders Recognized by HBA
Healthcare Businesswomen’s Association Spotlights Kasey Boynton and Feni Komline for Biopharma Industry ImpactMORRISVILLE, N.C., May 10, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Kasey Boynton, MPH, MBA, Director, Client Engagement, Real World Evidence & Late Phase, and Feni Komline, RN, BSN, Director, Engagement Center, Deployment Solutions, have been recognized by the Healthcare Businesswomen’
- Zacks
Syneos Health (SYNH) Q1 Earnings Top Estimates, Margins Up
Syneos Health's (SYNH) revenues increased year over year in the first quarter, led by strong performances by the Clinical Solutions and Commercial Solutions arms.
- American City Business Journals
Syneos Health names new CEO as revenues race past $5 billion
The company with about 28,000 employees has a new CEO following a year that saw revenues soar by double digits.
